论文部分内容阅读
[目的]通过大肠癌早诊早示范基地建设项目实施,使大肠癌能够早期发现、早期诊断、早期治疗,提高大肠癌生存率,降低大肠癌发病率和死亡率。[方法]根据卫生部专家组制定的《中国癌症筛查及早诊早治指南》,采用病史问卷调查、大便隐血试验(FOBT)进行初筛,在此基础上,对初筛出来的高危人群用电子肠镜作进一步检查。[结果]2007、2008年分别对海昌街道、袁花镇进行了筛查,两地40～74岁应检对象为25792人,实际接受筛查了22486人,顺应率为87.18%,初筛出高危人群3484例,占筛查人数的15.49%;进行肠镜检查2656例,顺应率为76.23%;检出大肠病变525例,检出率19.77%;接受治疗392例,占应治疗数的78.71%,经病理切片证实,其中:大肠癌18例(4.59%)、高级别瘤变12例(3.06%)、腺瘤153例(39.03%)、非腺瘤性息肉209例(53.32%)。[结论]开展大肠癌早诊早治筛查,对降低大肠癌死亡率和发病率、提高患者生存率和生活质量具有重要意义。
[Objective] Through the implementation of early demonstration base construction project of early diagnosis and treatment of colorectal cancer, it can make early detection, early diagnosis and early treatment of colorectal cancer and improve the survival rate of colorectal cancer and reduce the incidence and mortality of colorectal cancer. [Methods] According to the “Guidelines for Cancer Screening and Early Diagnosis and Early Treatment in China” formulated by the expert group of the Ministry of Health, preliminary questionnaire was conducted on the history questionnaire and fecal occult blood test (FOBT). On this basis, Electronic colonoscopy for further examination. [Results] In 2007 and 2008, Haichang Subdistrict and Yuanhua Town were screened respectively. The number of objects to be examined between 40-74 years old in both places was 25,792, and 22,486 persons were actually screened, with a compliance rate of 87.18% 3484 cases of high-risk population, accounting for 15.49% of the number of screening; colonoscopies 2656 cases, the compliance rate was 76.23%; detected colorectal lesions in 525 cases, the detection rate of 19.77%; 392 cases of treatment, accounting for the number of treatment 78.71% were confirmed by biopsy, including 18 cases (4.59%) of colorectal cancer, 12 cases (3.06%) of high grade tumor, 153 cases of adenoma (39.03%) and 209 cases of non adenomatous polyp (53.32% . [Conclusion] It is of great significance to carry out early diagnosis and treatment of colorectal cancer screening to reduce the mortality and morbidity of colorectal cancer and improve the survival rate and quality of life of patients.